O42: Development of an anti-sense oligonucleotide therapeutic targeting RhoBTB2-related epileptic encephalopathy

• Matthew Wheeler,
• Devon Bonner,
• Raquel Alvarez,
• Sara Emami,
• Richard Coca,
• Brandon Willis,
• Hector Mendez,
• Ruchi Patel,
• Kate Duong,
• Jennifer Arthur,
• Ioannis Karakikes,
• Jonathan Bernstein,
• Brenda Porter,
• Juliet Knowles,
• Kent Lloyd,
• Thomas LaRocca

Affiliations

Matthew Wheeler

Stanford University

Devon Bonner

Stanford University

Raquel Alvarez

Stanford University

Sara Emami

Stanford University

Richard Coca

Boston University

Brandon Willis

University of California, Davis

Hector Mendez

Stanford University

Ruchi Patel

Stanford University

Kate Duong

Stanford University

Jennifer Arthur

Stanford University

Ioannis Karakikes

Stanford University

Jonathan Bernstein

Stanford University

Brenda Porter

Stanford University

Juliet Knowles

Stanford University

Kent Lloyd

University of California, Davis

Thomas LaRocca

Stanford University